PCK
PAINCHEK FPO [PCK]
Healthcare · ASX Small Cap
$0.1700 +0.0%
Updated 2026-03-02 · Scores refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scans→ Score +1First seen: 2026-02-25
Score Breakdown
Technical57
Catalyst50
Sentiment50
Fundamental48
Momentum35
Risk Gate35
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Volatility contracting (breakout setup)
- Critical cash runway (1.0 quarters)
- 4C filed 2026-01-29
- Moderate P/S ratio (10.6x)
- Strong revenue growth (+25%)
- Near 52-week low (3% of range)
- Small-cap ($20-100M)
- Poor risk-adjusted momentum (Sharpe -2.1)
- Altman Z-Score in distress zone (1.32 < 1.81)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: (est. 2024-06-18)
Risk Signals
- Price below MAs (downtrend)
- Deeply negative margins (-228%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-44%)
Recent Catalysts
NONE Half Yearly Report and Accounts
NONE Update - Notification regarding unquoted securities - PCK
NONE Notification regarding unquoted securities - PCK
LOW Quarterly Activities/Appendix 4C Cash Flow Report
MEDIUM PainChek Business Update
Recent ASX Announcements
| 2026-02-27 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-11 | Update - Notification regarding unquoted securities - PCK |
| 2026-02-11 | Notification regarding unquoted securities - PCK |
| 2026-01-29 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
| 2026-01-29 | PainChek Business Update PRICE SENSITIVE |
Key Metrics
$35.5M
Market Cap
166K
Avg Volume
1.4x
Vol Ratio
$0.17 — $0.35
52-Week Range
N/A
Short Interest
1 qtrs
Cash Runway
-8647.6%
ROE
-228.2%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 64% |
| L | Leader vs Laggard | laggard | RS: -9 |
| I | Institutional Sponsorship | weak | Inst: 2% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #75 of 119 · Sector avg: 51
View all Healthcare signals →